Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]
Zhang Q, Zong L, Zhang H, et al. Onco Targets Ther. 2021;14:4275–4283. The authors have advised affiliation 1 on page 4275 is incorrect. The correct affiliation should read “Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University,...
Enregistré dans:
Auteurs principaux: | Zhang Q, Zong L, Zhang H, Xie W, Yang F, Sun W, Cui B, Zhang Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fdc0da68f5fe4ef1bd2cc7d9c646ea7e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India
par: Anoushika Mehan, et autres
Publié: (2021) -
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave
par: Xinfang Yu, et autres
Publié: (2021) -
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
par: Chunyi Shen, et autres
Publié: (2021) -
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
par: Hei Y, et autres
Publié: (2020) -
D-1 / PD-L1 EXPRESSION IN INVASIVE BREAST CARCINOMA / CANCER
par: Sammeen Salim, et autres
Publié: (2021)